961 research outputs found

    The influence of power and frequency on the filamentary behavior of a flowing DBD-application to the splitting of CO2

    Full text link
    In this experimental study, a flowing dielectric barrier discharge operating at atmospheric pressure is used for the splitting of CO2 into O2 and CO. The influence of the applied frequency and plasma power on the microdischarge properties is investigated to understand their role on the CO2 conversion. Electrical measurements are carried out to explain the conversion trends and to characterize the microdischarges through their number, their lifetime, their intensity and the induced electrical charge. Their influence on the gas and electrode temperatures is also evidenced through optical emission spectroscopy and infrared imaging. It is shown that, in our configuration, the conversion depends mostly on the charge delivered in the plasma and not on the effective plasma voltage when the applied power is modified. Similarly, at constant total current, a better conversion is observed at low frequencies, where a less filamentary discharge regime with a higher effective plasma voltage than that at a higher frequency is obtained

    Reduced exposure to calcineurin inhibitors in renal transplantation

    Get PDF
    Background: immunosuppressive regimens with the fewest possible toxic effects are desirable for transplant recipients. This study evaluated the efficacy and relative toxic effects of four immunosuppressive regimens. Methods: we randomly assigned 1645 renal-transplant recipients to receive standard-dose cyclosporine, mycophenolate mofetil, and corticosteroids, or daclizumab induction, mycophenolate mofetil, and corticosteroids in combination with low-dose cyclosporine, low-dose tacrolimus, or low-dose sirolimus. The primary end point was the estimated glomerular filtration rate (GFR), as calculated by the Cockcroft-Gault formula, 12 months after transplantation. Secondary end points included acute rejection and allograft survival. Results: the mean calculated GFR was higher in patients receiving low-dose tacrolimus (65.4 ml per minute) than in the other three groups (range, 56.7 to 59.4 ml per minute). The rate of biopsy-proven acute rejection was lower in patients receiving low-dose tacrolimus (12.3%) than in those receiving standard-dose cyclosporine (25.8%), low-dose cyclosporine (24.0%), or low-dose sirolimus (37.2%). Allograft survival differed significantly among the four groups (P=0.02) and was highest in the low-dose tacrolimus group (94.2%), followed by the low-dose cyclosporine group (93.1%), the standard-dose cyclosporine group (89.3%), and the low-dose sirolimus group (89.3%). Serious adverse events were more common in the low-dose sirolimus group than in the other groups (53.2% vs. a range of 43.4 to 44.3%), although a similar proportion of patients in each group had at least one adverse event during treatment (86.3 to 90.5%). Conclusions: a regimen of daclizumab, mycophenolate mofetil, and corticosteroids in combination with low-dose tacrolimus may be advantageous for renal function, allograft survival, and acute rejection rates, as compared with regimens containing daclizumab induction plus either low-dose cyclosporine or low-dose sirolimus or with standard-dose cyclosporine without induction

    Percepção do enfermeiro sobre promoção da saúde na Unidade de Terapia Intensiva

    Get PDF
    Objetivou-se relatar a percepção dos enfermeiros sobre a promoção da saúde, descrever ações de promoção da saúde e identificar dificuldades na realização de atividades de promoção da saúde na Unidade de Terapia Intensiva (UTI). Trata-se de um estudo descritivo, exploratório, qualitativo realizado com 31 enfermeiros de duas UTIs adulto e uma UTI neonatal de hospital de referência em Fortaleza, Ceará, Brasil, entre julho e agosto de 2009, mediante questionário. Os dados foram analisados e categorizados a partir da análise de conteúdo de Bardin. Emergiram as seguintes categorias e subcategorias: Conceito de promoção da saúde: visão biomédica x visão holística de promoção da saúde; Ações de promoção da saúde; Comunicação e apoio emocional ao paciente/família; Promoção da saúde na UTI; Promoção da saúde com enfoque na educação em saúde; e Dificuldades para o desenvolvimento de ações de promoção da saúde
    corecore